A new study published in the Journal of Bone & Joint Surgery suggests a connection between pain pumps and chondrolysis development.

An upsurge has been noted recently in orthopedic and multispecialty surgery centers interested in adding high acuity cases — total joint replacements, for example — to their current case mix. Since shifting more complex procedures from the acute care arena to an ambulatory setting is relatively new, the window of opportunity is open for ASCs to negotiate beneficial reimbursement terms for these cases in their existing payor contracts.

Here are 20 orthopedic and sports medicine physicians recently on the move.

Camille Van Vurst, RN, MBA, vice president of accountable care strategic advisory services at TriZetto Group, and Thomas Lundquist, MD, vice president of performance measures at BlueCross BlueShield of Tennessee, discuss the bundled payment program that was recently announced for joint replacements and arthroscopy. Ms. Van Vurst and Dr. Lundquist have been working with physician representatives from Tennessee Orthopaedic Alliance, Vanderbilt Medical Group, Knoxville Orthopaedic Clinic and Campbell Clinic to launch the program.

Here are 12 orthopedic surgeries for professional athletes.

Here are 10 sports medicine physicians on the move.

One year ago, the San Francisco Surgery Center (SFSC) acquired the world's first MAKOplasty robots for partial joint replacements in an outpatient surgery center. Since then, surgeons at the SFSC have performed over 50 procedures using this technology. Jeff Wong, SFSC's Administrator, and orthopedic surgeon, Kevin R. Stone MD, discuss the benefits and challenges of incorporating this technology into a surgery center and where they believe robotics is headed.

Here are 15 statistics comparing orthopedic surgeon compensation from 2010 to 2011. The data comes from Medscape Physician Compensation Reports 2011 and 2012, based on compensation data from the previous year. Median income declined from 2010 to 2011 and 6 percent more orthopedic surgeons said they saw a compensation decrease than reported an increase from 2010 to 2011.

GelrinC, developed by Regentis Biomaterials, is a new biomaterial solution for cartilage repair that can be used during orthopedic procedures. The material is a combination of a synthetic biomaterial and fibrinogen, which enables the material to degrade in a unique fashion.

Here are 10 recent orthopedic surgeries for professional athletes.